Efficient tumour formation by single human melanoma cells

A fundamental question in cancer biology is whether cells with tumorigenic potential are common or rare within human cancers. Studies on diverse cancers, including melanoma, have indicated that only rare human cancer cells (0.1–0.0001%) form tumours when transplanted into non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. However, the extent to which NOD/SCID mice underestimate the frequency of tumorigenic human cancer cells has been uncertain. Here we show that modified xenotransplantation assay conditions, including the use of more highly immunocompromised NOD/SCID interleukin-2 receptor gamma chain null (Il2rg) mice, can increase the detection of tumorigenic melanoma cells by several orders of magnitude. In limiting dilution assays, approximately 25% of unselected melanoma cells from 12 different patients, including cells from primary and metastatic melanomas obtained directly from patients, formed tumours under these more permissive conditions. In single-cell transplants, an average of 27% of unselected melanoma cells from four different patients formed tumours. Modifications to xenotransplantation assays can therefore dramatically increase the detectable frequency of tumorigenic cells, demonstrating that they are common in some human cancers.

[1]  Alan Horwich,et al.  Testicular germ-cell cancer , 2006, The Lancet.

[2]  Michael F. Clarke,et al.  Applying the principles of stem-cell biology to cancer , 2003, Nature Reviews Cancer.

[3]  H. Kleinman,et al.  Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel. , 1991, Journal of the National Cancer Institute.

[4]  R. McLendon,et al.  Targeting cancer stem cells through L1CAM suppresses glioma growth. , 2008, Cancer research.

[5]  P. Dalerba,et al.  Identification of pancreatic cancer stem cells. , 2006, Cancer research.

[6]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[7]  H. Kleinman,et al.  Matrigel: basement membrane matrix with biological activity. , 2005, Seminars in cancer biology.

[8]  S. Morrison,et al.  Hirschsprung Disease Is Linked to Defects in Neural Crest Stem Cell Function , 2003, Science.

[9]  C. Sherr,et al.  Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia. , 2007, Genes & development.

[10]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[11]  N. Goulden,et al.  Characterization of acute lymphoblastic leukemia progenitor cells. , 2004, Blood.

[12]  Gwendolyn R. Goss,et al.  Theory and Practice of Histological Techniques , 2009 .

[13]  J. Dick,et al.  High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. , 1998, Blood.

[14]  S. Lowe,et al.  Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. , 2005, Cancer research.

[15]  Michael F. Clarke,et al.  Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.

[16]  S. Morrison,et al.  Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells , 2006, Nature.

[17]  Mohamed H. Sayegh,et al.  Identification of cells initiating human melanomas , 2008, Nature.

[18]  J. Dick,et al.  Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity , 2004, Nature Immunology.

[19]  François Vaillant,et al.  Generation of a functional mammary gland from a single stem cell , 2006, Nature.

[20]  H. Suemizu,et al.  Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice. , 2007, International journal of oncology.

[21]  J. Dick,et al.  Cancer stem cells: lessons from leukemia. , 2005, Trends in cell biology.

[22]  R. Taichman,et al.  Ablation of Proliferating Marrow with 5‐Fluorouracil Allows Partial Purification of Mesenchymal Stem Cells , 2006, Stem cells.

[23]  Mamoru Ito,et al.  NOD / SCID / cnull mouse : an excellent recipient mouse model for engraftment of human cells , 2002 .

[24]  J. Sotto,et al.  Fitting limiting dilution experiments with generalized linear models results in a test of the single-hit Poisson assumption. , 1996, Journal of immunological methods.

[25]  J. Dick,et al.  Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells. , 2005, Blood.

[26]  K. Ballen,et al.  Regulation of human short-term repopulating cell (STRC) engraftment in NOD/SCID mice by host CD122+ cells. , 2003, Experimental hematology.

[27]  G. Pruneri,et al.  Human acute leukemia cells injected in NOD/LtSz‐scid/IL‐2Rγ null mice generate a faster and more efficient disease compared to other NOD/scid‐related strains , 2008, International journal of cancer.

[28]  G. B. Pierce,et al.  MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS. , 1964, Cancer research.

[29]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Dick,et al.  Comment on "Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells" , 2007, Science.

[31]  M. Kotb,et al.  Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2Rγnull Mice Engrafted with Mobilized Human Hemopoietic Stem Cells 12 , 2004, The Journal of Immunology.

[32]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[33]  Aleksandar Dakic,et al.  Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells , 2007, Science.

[34]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[35]  C. Eaves,et al.  Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors , 2003, Leukemia.

[36]  M. Cleary,et al.  Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. , 2006, Cancer cell.

[37]  W. Sadee,et al.  ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. , 2005, Cancer research.

[38]  H. Suemizu,et al.  Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice. , 2008, International journal of oncology.

[39]  H. Kleinman,et al.  Basement membrane and the SIKVAV laminin-derived peptide promote tumor growth and metastases , 1991, Cancer and Metastasis Reviews.

[40]  T. Nakajima,et al.  Immunohistochemical demonstration of S 100 protein in malignant melanoma and pigmented nevus, and its diagnostic application , 1982, Cancer.

[41]  Satoshi Tanaka,et al.  Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region , 2007, Nature Biotechnology.

[42]  T. P. Pretlow,et al.  Transplantation of human prostatic carcinoma into nude mice in Matrigel. , 1991, Cancer research.

[43]  B. Alman,et al.  Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. , 2007, Cancer research.